There are a few contraindications: People with family history of medullary thyroid cancer or a rare genetic syndrome called MEN2 should not take GLP-1s, for instance
ProPeptide publishes two Janoshik reports for the retatrutide pen lineup: the bulk solution that fills the cartridges (batch RET-20-V-2604-001, 99.741% HPLC purity) and a separate finished-cartridge test (batch RET-20-C-2604-001, 99.841% HPLC purity, the 20mg pen)
These lifestyle behaviors a cornerstone of the WeightWatchers Program are one reason why members who discontinued GLP-1 medication not only maintained their weight loss, but dropped an additional 1.8% of their body weight after 13 weeks.* Also, make sure you time it right
Delta sleep-inducing peptide (DSIP) Strength: 5 mg A sleep-support peptide option frequently discussed in broader recovery and rest-centered wellness plans
This pattern suggests Canadian approval for Retatrutide could occur around 2028-2029 if the US approval timeline holds at 2026-2027
Track symptoms, get personalised treatment and monitor your recovery via the app